Medtech Co. Haemonetics Inks $253M Deal To Buy OpSens
Haemonetics Corp. has agreed to acquire Canadian medical device maker OpSens Inc. in an all-cash deal valued at CA$345 million ($253 million), or CA$2.90 per share, according a news release from...To view the full article, register now.
Already a subscriber? Click here to view full article